(Q62811955)

English

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Protocol IDN-6556-18 - A Post Treatment Follow-up Study for Liver Disease Subjects With or Without Liver Cirrhosis After Receiving Emricasan or Placebo (English)

0 references

medical condition

liver cirrhosis

0 references

metabolic dysfunction–associated steatotic liver disease

0 references

country

United States of America

0 references

start time

27 February 2018

0 references

end time

31 January 2022

0 references

number of participants

832

0 references

research subject recruitment status

terminated

0 references

minimum age

18 year

0 references

study type

observational study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03479125

0 references

(Q62811955)

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)